These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 32872332)

  • 1. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.
    Smetana K; Rosel D; BrÁbek J
    In Vivo; 2020; 34(5):3027-3028. PubMed ID: 32871847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of Δ
    Mohammed A; Alghetaa HK; Zhou J; Chatterjee S; Nagarkatti P; Nagarkatti M
    Br J Pharmacol; 2020 Nov; 177(22):5078-5095. PubMed ID: 32754917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut.
    Alghetaa H; Mohammed A; Zhou J; Singh N; Nagarkatti M; Nagarkatti P
    Pharmacol Res; 2021 May; 167():105548. PubMed ID: 33722710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.
    Ray PR; Wangzhou A; Ghneim N; Yousuf MS; Paige C; Tavares-Ferreira D; Mwirigi JM; Shiers S; Sankaranarayanan I; McFarland AJ; Neerukonda SV; Davidson S; Dussor G; Burton MD; Price TJ
    Brain Behav Immun; 2020 Oct; 89():559-568. PubMed ID: 32497778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
    Lohse A; Klopfenstein T; Balblanc JC; Royer PY; Bossert M; Gendrin V; Charpentier A; Bozgan AM; Badie J; Bourgoin C; Contreras R; Mazurier I; Conrozier T; Zayet S
    Microbes Infect; 2020 Oct; 22(9):500-503. PubMed ID: 32574789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
    Soto M; diZerega G; Rodgers KE
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
    Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
    Front Immunol; 2020; 11():588724. PubMed ID: 33117402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of Δ9-Tetrahydrocannabinol (THC) Post-Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity.
    Mohammed A; Alghetaa H; Sultan M; Singh NP; Nagarkatti P; Nagarkatti M
    Front Pharmacol; 2020; 11():893. PubMed ID: 32612530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
    Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells.
    Rao R; Nagarkatti PS; Nagarkatti M
    Br J Pharmacol; 2015 Apr; 172(7):1792-806. PubMed ID: 25425209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome.
    Tamimi F; Abusamak M; Akkanti B; Chen Z; Yoo SH; Karmouty-Quintana H
    Br J Pharmacol; 2020 Nov; 177(21):4845-4850. PubMed ID: 32442317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the NLRP3 Inflammasome in Severe COVID-19.
    Freeman TL; Swartz TH
    Front Immunol; 2020; 11():1518. PubMed ID: 32655582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.
    Convertino I; Tuccori M; Ferraro S; Valdiserra G; Cappello E; Focosi D; Blandizzi C
    Crit Care; 2020 Jun; 24(1):331. PubMed ID: 32527304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rationale for targeting the P2X7 receptor in Coronavirus disease 19.
    Di Virgilio F; Tang Y; Sarti AC; Rossato M
    Br J Pharmacol; 2020 Nov; 177(21):4990-4994. PubMed ID: 32441783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis.
    Sultan M; Wilson K; Abdulla OA; Busbee PB; Hall A; Carter T; Singh N; Chatterjee S; Nagarkatti P; Nagarkatti M
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COVID-19 Cytokine Storm; What We Know So Far.
    Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R
    Front Immunol; 2020; 11():1446. PubMed ID: 32612617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.